An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts

Abstract excerpt

The erythroid growth factor erythropoietin (Epo) is produced by renal interstitial fibroblasts, called REP (renal Epo-producing) cells, in a hypoxia-inducible manner. In chronic kidney disease (CKD), REP cells lose their Epo-production ability, leading to renal anaemia. Concurrently, REP cells are suggested to be transformed into myofibroblasts, which are the major player of renal fibrosis. Although establishment...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chronic Kidney Disease and Diabetes
• Share to Erythropoietin and Anemia Treatment
• Share to Renal and related cancers